Luminor Medical Technologies Inc. (LMT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 195,000 | 228,000 | 213,000 | 201,000 | 199,000 |
| Income taxes - deferred | -12,000 | N/A | N/A | N/A | N/A |
| Accounts receivable | -900,000 | 500,000 | 37,000 | -3,000 | -549,000 |
| Accounts payable and accrued liabilities | 745,000 | -718,000 | 107,000 | 30,000 | 217,000 |
| Other Working Capital | 855,000 | -851,000 | -1,104,000 | 1,428,000 | -400,000 |
| Other Operating Activity | 801,000 | 1,001,000 | 1,260,000 | -431,000 | 2,182,000 |
| Operating Cash Flow | $1,684,000 | $160,000 | $513,000 | $1,225,000 | $1,649,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -95,000 | -426,000 | -171,000 | -131,000 | -92,000 |
| Net Acquisitions | N/A | 691,000 | -19,000 | -3,000 | -19,000 |
| Purchase Of Investment | N/A | N/A | 110,000 | N/A | N/A |
| Sale Of Investment | 10,000 | N/A | N/A | N/A | 107,000 |
| Other Investing Activity | 22,000 | 283,000 | 17,000 | -662,000 | -4,000 |
| Investing Cash Flow | $-63,000 | $548,000 | $-63,000 | $-796,000 | $-8,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 43,000 | N/A | 20,000 | 13,000 | 24,000 |
| Common Stock Repurchased | -314,000 | -854,000 | -319,000 | -731,000 | -516,000 |
| Dividend Paid | -266,000 | -269,000 | -229,000 | -233,000 | -238,000 |
| Other Financing Activity | 0 | 16,000 | -8,000 | -39,000 | 0 |
| Financing Cash Flow | $-537,000 | $-1,107,000 | $-536,000 | $-990,000 | $-730,000 |
| Exchange Rate Effect | 12,000 | 4,000 | 20,000 | -5,000 | -14,000 |
| Beginning Cash Position | 2,261,000 | 2,656,000 | 2,722,000 | 3,288,000 | 2,391,000 |
| End Cash Position | 3,357,000 | 2,261,000 | 2,656,000 | 2,722,000 | 3,288,000 |
| Net Cash Flow | $1,084,000 | $-399,000 | $-86,000 | $-561,000 | $911,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,684,000 | 160,000 | 513,000 | 1,225,000 | 1,649,000 |
| Capital Expenditure | -95,000 | -426,000 | -171,000 | -131,000 | -92,000 |
| Free Cash Flow | 1,589,000 | -266,000 | 342,000 | 1,094,000 | 1,557,000 |